A novel TOX-nanoluciferase reporter mouse for exploring modulators of T cell exhaustion
The Journal of Immunology · 01.06.2025 · 214 (6) · 1398-1409
DOI: 10.1093/jimmun/vkaf009 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 22.03.2025. Verfasst von Ling Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: T-Lymphocytes, Cytotoxic, Luciferases, CD8-Positive T-Lymphocytes, High Mobility Group Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: department of Immunology, China Scholarship Council, KWF.
Abstract (Originalsprache)
Cytotoxic T cell (CTL) exhaustion is driven by chronic T cell receptor (TCR) stimulation, leading to a dysfunctional state of cells. Exhausted CTLs exhibit diminished effector function against chronic infections and cancers. Therefore, reducing CTL exhaustion may re-establish effective adaptive immune responses. One feature of exhausted CTLs is the sustained and stable expression of transcription factor thymocyte selection-associated high mobility group box (TOX). Downregulating TOX expression in CD8+ T cells enhances their antitumor activities and improves immune checkpoint blockade (ICB) efficiency. We generated a reporter transgenic mouse to rapidly detect the expression of TOX by measuring luciferase activity. We knocked in a reporter cassette containing NanoLuc bioluminescent luciferase (Nluc) into the Tox gene locus by CRISPR/Cas9 (Tox-NLuc mice). We further generated Tox-NLuc-OT-I mice by crossing Tox-NLuc mice with OT-I mice, which allows the induction of CTL exhaustion in vitro by repeated stimulation of CD8+ T cells with OVA (257–264) peptide. Luciferase assays showed that higher luminescent signals were detected in exhausted CTLs compared to non-exhausted CTLs, which can be visualized by bioluminescence imaging. Bioluminescence changes were confirmed by measuring TOX expression by flow cytometry. The luminescence in exhausted CTLs decreased significantly when cells treated with ibrutinib and bryostatin-1, drugs that were found to directly modulate T cell exhaustion and decrease TOX expression. In summary, we have developed a novel TOX-nanoluciferase-based reporter system that can be used to monitor TOX expression and may facilitate the screening of molecules that modulate CTL exhaustion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Cell Biology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Förderung
- department of Immunology
- China Scholarship Council
- KWF
Zitieren
APA
Li, L., Mueller, Y. M., Hioki, K., den Dekker, R. J. H., Brouwers-Haspels, I., Mezzanotte, L., Maas, A., Erkeland, S., & Katsikis, P. D. (2025). A novel TOX-nanoluciferase reporter mouse for exploring modulators of T cell exhaustion. The Journal of Immunology, 214(6), 1398-1409. https://doi.org/10.1093/jimmun/vkaf009
Vancouver
Li L, Mueller YM, Hioki K, den Dekker RJH, Brouwers-Haspels I, Mezzanotte L, et al. A novel TOX-nanoluciferase reporter mouse for exploring modulators of T cell exhaustion. The Journal of Immunology. 2025;214(6):1398-1409. doi:10.1093/jimmun/vkaf009
BibTeX
@article{Li2025,
author = {Li, Ling and Mueller, Yvonne M and Hioki, Kou and den Dekker, Renske J H and Brouwers-Haspels, Inge and Mezzanotte, Laura and Maas, Alex and Erkeland, Stefan and Katsikis, Peter D},
title = {A novel TOX-nanoluciferase reporter mouse for exploring modulators of T cell exhaustion},
journal = {The Journal of Immunology},
year = {2025},
volume = {214},
number = {6},
pages = {1398--1409},
doi = {10.1093/jimmun/vkaf009}
}
EUVIMED